Pharmaceuticals News
Subscribe to pharmaceutical news about research, development, manufacturing and marketing of prescription and over the counter drugs. Find the latest on FDA approvals, compliance, competition, management and distribution of pharmaceutical products as well as pharmaceutical business intelligence.
GSK and Lundbeck Present on Improving Drug-Drug Interaction at ADMET 2016
SMi reports: SMi’s 11th annual conference and exhibition on ADMET will return to London on the 13th-14th June 2016. - April 13, 2016 - SAE Media Group
Virun® at Ingredient Marketplace, Patent Grant in S. Korea, New Product Launches, Debut of Lightbulb Virun T-Shirts, and Webinar Controversy
VIRUN® plans on taking Orlando by storm at Ingredient Marketplace, where Virun’s Esolv® technology will take center stage, and Virun’s unique Omega smoothies and beverages will be available for sampling. South Korea granted Virun yet another patent protecting its unique technology. Virun launches new products and a new t-shirt. Virun’s latest webinar, “Inside Virun,” sparks controversy, and provides new business opportunities. - April 12, 2016 - VIRUN
Attendee List Released for SMi's 13th Annual Controlled Release Conference
SMi's 13th annual Controlled Release conference, taking place on 18th - 19th April 2016 in London, UK, will feature case studies from leading regulatory bodies and an array of major global pharmaceutical companies. - April 09, 2016 - SAE Media Group
Patent Issued for Stable Vitamin C Formulation
Dr. Andrew Chadeayne has been issued a patent for a stable form of vitamin C - which does not breakdown in liquid solution. While vitamin C is useful anywhere that oxidation is a problem, it breaks down rapidly. According to the inventor, Dr. Chadeayne, “This is the first stable solution of... - April 06, 2016 - SwimSpray
Blazers VS Nugs Portland Trailblazers Take on the Denver Nuggets for the Blazers Last Home Game of the Season
The Seattle SuperChronic Cafe Presents "Blazers VS Nugs" private suite (sky-box) at the Moda Center with retired Trailblazer Cliff Robinson, aka Uncle Spliffy Wednesday April 13th. This event at the Blazers VS Nuggets NBA game is an opportunity to normalize cannabis in a professional setting, while promoting an Active Cannabis Lifestyle. More on FB @SuperChronic_Cafe - April 05, 2016 - SuperChronic Cafe
Florian M. Ward, Ph.D. Recognized as a VIP for 2016 by Strathmore's Who's Who Worldwide Publication
Florian M. Ward, Ph.D. of Bel Air, Maryland has been recognized as a VIP for 2016 by Strathmore’s Who’s Who Worldwide Edition for her outstanding contributions and achievements in the fields of consulting and inventing. About Florian M. Ward, Ph.D. Dr. Ward has over 20 years experience... - April 05, 2016 - Strathmore Worldwide
SMi’s 3rd Peptides Conference to Feature a Live Learning Lab on Peptide Development and Manufacturing
Registration is now live for SMi Group's 3rd Peptides Conference which takes place in London on 6th - 7th July at the Holiday Inn Kensington Forum. - April 04, 2016 - SAE Media Group
MHRA and US FDA to Discuss Innovation in Controlled Release
SMi's 13th annual Controlled Release conference, taking place on 18th - 19th April 2016 in London, will feature case studies from leading regulatory bodies and an array of major global pharmaceutical companies. - March 31, 2016 - SAE Media Group
SAPA Successfully Organized Workshop on Regulatory Affairs of Botanical and Chinese Medicines
SAPA organized a workshop at DoubleTree Conference Center located in Somerset, NJ. With the generous support of Shimadzu China Corporation, SAPA invited several prominent speakers to present at this workshop: Mr. Hongyu Jin from China Food and Drug Administration (CFDA), Dr. Jinhui Dou from US Food and Drug Administration (FDA), and Mr. Andrew Jiang - CEO of Aleon Pharma International. The workshop was hosted by regulatory affairs expert Dr. Xin Du and attracted nearly 100 attendees. - March 29, 2016 - Sino-American Pharmaceutical Professionals Association
Global Medical Solutions to Sell China Operations to Yantai Dongcheng Biochemicals
Global Medical Solutions to sell China Operations to Yantai Dongcheng Biochemicals and enter into a long-term collaborative partnership in China. - March 28, 2016 - Global Medical Solutions
AXSource Global Launches an Enhanced ERP Solution for Life Sciences Companies
AXOQCS™ is complete business solution developed for Microsoft Dynamics AX that provides quality and compliance functionality. Pharmaceutical and Medical Devices manufacturers need a solution that is flexible, responsive, and integrated. AXOQCS™ is a unique ERP solution for Pharma and Life Sciences manufacturers that streamlines and integrates quality and compliance processes, helping them comply with FDA Good Manufacturing Practices while maintaining efficiency and profitability across business. - March 26, 2016 - AxSource
New Bioreactor Tubing Kits from AdvantaPure(R) Speed Turnaround and Increase Processing Capacity; Single-Use and Customizable for Benchtop Bioreactors
Custom, Single-Use Bioreactor Tubing Kits, new from AdvantaPure, contain tubing, filters and connectors for harvest, vent, sparge and addition lines used in benchtop bioreactors. Because the kits arrive preassembled, they provide quicker turnaround time, convenience and less chance of cross contamination. Platinum-cured silicone or AdvantaFlex(R) TPE tubing may be selected as the tubing components in each kit. This product will be exhibited at Interphex booth 3055. - March 24, 2016 - AdvantaPure
Global Pharmaceutical Excipient Market to Grow US$ 7,415.2 Mn by 2021: Persistence Market Research
The global pharmaceutical excipients market is estimated to be valued at US$ 7,415.2 Mn by 2021 end, with various markets registering significant CAGRs during the forecast period. - March 23, 2016 - Persistence Market Research
Best Health Care Website to be Named by Web Marketing Association in 20th Annual WebAward Competition
The best healthcare websites in the world will be named as part of the Web Marketing Association's 20th annual international WebAward Competition for Web site development at www.webaward.org. The WebAwards is the standards-defining competition that sets benchmarks for 96 industries, including healthcare, healthcare provider, medical, medical equipment, biotechnology and pharmaceutical websites, based on the seven criteria of a successful web site. - March 18, 2016 - Web Marketing Association
Sanofi-Aventis and Roche Discuss Linking PK with Safety at ADMET 2016
SMi are delighted to have Sanofi-Aventis and Roche amongst the speaker line-up for the 11th annual ADMET conference and exhibition which takes place on the 13th-14th June 2016, London, UK. - March 15, 2016 - SAE Media Group
Biogen, Teva, Medimmune, Pfizer, Shire to Share Insights and Project Updates at Pre-Filled Syringes West Coast 2016
SMi Group Reports (2016.03. 08, San Diego, California, USA): Registration is now open to attend Pre-Filled Syringes West Coast 2016 in San Diego. - March 12, 2016 - SAE Media Group
A Tale of Two New Hepatitis C Drugs
Despite discount, Merck’s just approved Zepatier unlikely to win share with most US payers, except in Medicaid, according to RxScorecard™. New combo from Gilead could ensure company’s dominant position among US payers. - March 11, 2016 - Real Endpoints
Earn CPD Points as You Prepare Yourself for New Compliance Guidelines
SMi Training's CPD accredited masterclass: “Compliance with the New Regulations for Medical Devices and In Vitro Diagnostic Products” will take place on the 4th April in London, UK. - March 11, 2016 - SAE Media Group
Reducing Risk with Containment of Highly Potent API’s Addressed Later This Month
SMi Training's CPD accredited masterclass: “Containment of Highly Potent API’s” will take place on the 22nd March 2016 in London, UK. - March 11, 2016 - SAE Media Group
The 2016 SAPA Career Forum Discussions with Young Professionals
On February 27, 2016, Sino-American Pharmaceutical Professionals Association (SAPA) hosted a career forum with young professionals at Rutgers University. This forum is co-organized by the Rutgers University iJOBS program, Rutgers Chinese Students and Scholars Association, Association of Chinese... - March 10, 2016 - Sino-American Pharmaceutical Professionals Association
Addressing the Challenges in Biomanufacturing
The life sciences industry is evolving on a global scale. Shifting market demands, health care reforms and more stringent regulations are presenting new challenges to the industry at large. Taking a holistic approach to the challenges and opportunities that biomanufacturers face, Generis' American Biomanufacaturing Summit 2016 will present attendees with first-hand case studies, strategies and best practices to advance manufacturing excellence, drive innovation and develop the necessary leaders. - March 10, 2016 - Generis Group
New Podcast “How Organizations are Navigating Risk Based Approaches in Clinical Trials” Now Available on WorldCongress.com
UCB Biosciences, Inc.’s Director/Head, Risk Based Monitoring, Justin, Stark, addresses centralized monitoring and on-site monitoring and how organizations are navigating risk based approaches in a new podcast available on the World Congress website. The podcast is geared toward those involved in clinical trial design, operations and risk management. - March 09, 2016 - World Congress
Makers Nutrition Launches Premium Stock Formulas
Fast-Growing Nutraceutical Company Offers Nine Popular Stock Formulas to Vitamin and Supplement Businesses - March 08, 2016 - Makers Nutrition, LLC
Versaic Launches Solution to Streamline Medical Affairs for Pharmaceuticals
New solution integrates easy to use interface, fully customizable process, time-saving reporting features, and ongoing support from dedicated client success managers. - March 03, 2016 - Versaic
Biobanking Conference to Tackle Regulatory Updates and Impacts on Industry
SMi Group reports (2016.29.02 – London, UK): Registration is now live for the 6th annual Biobanking Conference and Exhibition on 20-21 June at the Holiday Inn Kensington Forum, London, UK. - March 02, 2016 - SAE Media Group
Ixogel®: Agreement on Special Protocol Assessment (SPA) by the US Food and Drug Administration for the Prevention of Lyme Disease
Ixodes AG, a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention of Lyme Disease, today announced that the company has reached agreement with the US Food and Drug Administration (FDA) on the phase III protocol according to the Special Protocol... - March 01, 2016 - Ixodes AG
AgmaSet for Nerve Health Launched in the Philippines
Gilad&Gilad, the exclusive manufacturer and supplier of AgmaSet®, a unique supplements for nerve health, is collaborating with JCS Pharmaceuticals Inc. for distribution in the Philippines According to Dr. Gad M. Gilad, CEO of Gilad&Gilad, "The Philippines Ministry of Health has... - March 01, 2016 - Gilad&Gilad
Recursion Pharmaceuticals Supports White House Precision Medicine Initiative
Recursion Pharmaceuticals today announced that it is part of a group of nationally recognized private and public institutions making commitments as part of President Obama's Precision Medicine Initiative to rapidly find new treatments for ultra-rare genetic diseases. - February 25, 2016 - Recursion Pharmaceuticals
Makers Nutrition Hires Stephen Finnegan as General Manager
Rapidly growing nutraceutical company turns to seasoned executive to help lead expansion. - February 25, 2016 - Makers Nutrition, LLC
Roche, GSK, Merck Serono, Sanofi-Aventis and Many More Will Meet in June at 11th Annual ADMET Conference and Exhibition
SMi Group reports: Big Pharma will meet at SMi’s 11th annual ADMET conference and exhibition which will take place on the 13th and 14th June 2016 in London, UK. - February 25, 2016 - SAE Media Group
Wego Health to Demonstrate the Importance of Patient Influencers During ePharma Summit 2016
Company will ask for a single question to show how the pharmaceutical industry can benefit from engaging patient community leaders. - February 24, 2016 - Wego Health
Agenda Now Released for the 5th Annual ADC Summit in London
SMI Reports: Agenda for the 5th annual ADC Summit presents a lineup of expert speakers from the ADC industry elite. - February 19, 2016 - SAE Media Group
Clarify Regulatory Uncertainties with the MHRA and US FDA at SMi’s 13th Annual Controlled Release Conference
SMi's 13th annual Controlled Release conference, taking place on 18-19 April 2016 in London, will feature case studies and project updates from leading regulatory bodies and global pharmaceutical companies. - February 19, 2016 - SAE Media Group
Agenda Released for Immunogenicity 2016: Accelerating Commercialisation of Your Next Gen Biotherapeutics
SMi Group reports: (17.02.2016, London): The agenda has now been released for SMi’s 3rd annual Immunogenicity conference which will take place on the 13th and 14th June 2016 in London, UK. - February 19, 2016 - SAE Media Group
Key Questions on Compliance with New Regulations for Medical Devices and In Vitro Diagnostic Products Addressed This April
SMi Training's CPD accredited masterclass: “Compliance with the New Regulations for Medical Devices and In Vitro Diagnostic Products” will take place on the 4th April in London, UK. - February 19, 2016 - SAE Media Group
MHRA, BARDA, European Commission and Big Pharma Gather Next Month at 18th Annual Superbugs & Superdrugs Summit: Attendee List Released
SMi Group have released a preliminary list of confirmed attendees for the 18th annual conference on Superbugs & Superdrugs taking place on 16th and 17th March 2016. - February 17, 2016 - SAE Media Group
Tabula Rasa Healthcare Pharmacy Simulation Software Tested by Schools of Pharmacy
Medication treatment is the most common medical intervention. Its imprecise use contributes to an estimated 45-50 million adverse drug events annually. Tabula Rasa's suite of software solutions provide prescribers, pharmacists and healthcare organizations with sophisticated and innovative tools to better manage the medication-related needs of patients. NiaRx provides electronic health record training and patient-case simulation for pharmacy students, the future of tomorrow's caregiving team. - February 15, 2016 - Tabula Rasa HealthCare
NuvOx Pharma receives FDA Orphan Drug Designation for Oxygen Therapeutic for Vaso-occlusive Crisis and Acute Chest Syndrome in Sickle Cell Disease
Tucson based pharmaceutical company NuvOx Pharma announced today that it has secured orphan drug designation from the FDA for its investigational drug NVX-508 for vaso-occlusive crisis (VOC) and acute chest syndrome (ACS) in sickle cell disease. VOC is one of the most severe complications of... - February 14, 2016 - NuvOx Therapeutics
SMi’s Premier Pre-Filled Syringes Event Series to Launch in the West Coast
SMi Group proudly presents the inaugural Pre-Filled Syringes Conference, taking place in Mission Bay, San Diego, USA on June 6th -7th 2016. - February 14, 2016 - SAE Media Group
Exclusive Interviews with the MHRA and the US FDA Released Ahead of Controlled Release 2016
SMi's 13th annual Controlled Release conference, taking place on 18th - 19th April 2016 in London, will feature an array of case studies and project updates from major global pharmaceutical companies and leading regulatory bodies. - February 14, 2016 - SAE Media Group
NuvOx Pharma Announces FDA Acceptance of IND to Initiate Clinical Trial for Vaso-Occlusive Crisis in Sickle Cell Disease
The FDA has notified NuvOx Pharma that it may proceed with a clinical trial for its Investigational New Drug (IND), NVX-508 for vaso-occlusive crisis (VOC) and acute chest syndrome (ACS) in sickle cell disease. VOC is one of the most severe complications of sickle cell disease and it typically... - February 13, 2016 - NuvOx Therapeutics
Real Endpoints’ RxScorecard™ Predicted Launch Failure of Major New Anti-Cholesterol Drugs
Analysis from 2015 showed that because PCSK9 inhibitors had not proved more than incremental value for most patients, payers would dramatically restrict their usage. Poor Q4 sales show that’s exactly what happened. - February 12, 2016 - Real Endpoints
Clinical Progress in Pancreatic Cancer Therapy Unveiled Next Week in London
Silenseed present exclusive clinical evidence on the effectiveness of siRNA against mutated KRAS in pancreatic cancer at RNA Therapeutics 2016 - February 11, 2016 - SAE Media Group
Agenda Released for ADMET 2016: Linking ADME and PK with Safety to an Overall Assessment of Risk and Benefit
SMi Group reports: (09.02.2016, London): The agenda has now been released for SMi’s 11th annual ADMET conference and exhibition which will take place on the 13th and 14th June 2016 in London, UK. - February 11, 2016 - SAE Media Group
Survey Reveals that Serialization Investments to Meet DSCSA Mandates are Expected to Deliver Business Value beyond Compliance
Improved returns and recall management are imperative goals cited by 42% of respondents. - February 09, 2016 - Acsis Inc.
Webinar to Explore "Serialization Lessons from the Front Lines of Distribution"
Acsis, AmerisourceBergen and Excellis discuss how serialization investments to meet DSCSA mandates can – and should – deliver business value beyond compliance. - February 06, 2016 - Acsis Inc.
Leading Expert from Medimmune to Chair 5th ADC Summit in London
SMI Group Reports (04.02.2016 – London, UK) Now in its fifth year and following the success of previous events, SMi's ADC Summit takes place in London on 23-24 May 2016. - February 06, 2016 - SAE Media Group
Coalition Forms to Study Medication Risk in Workforce Populations
Tabula Rasa HealthCare and The Greater Philadelphia Business Coalition on Health have partnered to examine the extent of medication risk in a diverse workforce population and the opportunities to mitigate that risk for the benefit of improving the health and welfare of employees and reducing unnecessary health care costs. - February 01, 2016 - Tabula Rasa HealthCare
Leading Pharmaceutical Companies to Speak at the 5th ADC Summit in London
Returning for its 5th year and following on from the major success of previous events, SMi’s ADC Summit brings together leading pharmaceutical companies to discuss ADC developments in London, UK on 23 – 24 May 2016. - January 30, 2016 - SAE Media Group
MHRA and US FDA Confirmed to Speak at Controlled Release 2016
SMi's 13th annual Controlled Release conference, taking place on 18th - 19th April 2016 in London, will feature case studies from an array of global pharmaceutical companies including GSK, Ipsen, Novo Nordisk, MedImmune, AstraZeneca, Lundbeck, Merck, UCB Pharma, Diurnal and more. - January 30, 2016 - SAE Media Group